DV Trading LLC Trims Stake in Liquidia Corporation $LQDA

DV Trading LLC lessened its position in Liquidia Corporation (NASDAQ:LQDA) by 70.7% in the 1st quarter, Holdings Channel.com reports. The fund owned 17,000 shares of the company’s stock after selling 40,928 shares during the period. DV Trading LLC’s holdings in Liquidia were worth $642,000 at the end of the most recent quarter.

Other hedge funds also recently added to or reduced their stakes in the company. Covestor Ltd lifted its stake in Liquidia by 41.9% in the fourth quarter. Covestor Ltd now owns 1,216 shares of the company’s stock worth $42,000 after purchasing an additional 359 shares during the last quarter. PNC Financial Services Group Inc. grew its stake in shares of Liquidia by 7.2% during the fourth quarter. PNC Financial Services Group Inc. now owns 6,304 shares of the company’s stock valued at $217,000 after buying an additional 422 shares during the last quarter. Quantinno Capital Management LP raised its holdings in shares of Liquidia by 3.6% in the first quarter. Quantinno Capital Management LP now owns 17,165 shares of the company’s stock worth $648,000 after buying an additional 589 shares during the period. Northwestern Mutual Wealth Management Co. purchased a new stake in shares of Liquidia in the fourth quarter worth approximately $25,000. Finally, ProShare Advisors LLC lifted its stake in shares of Liquidia by 7.1% during the 4th quarter. ProShare Advisors LLC now owns 11,756 shares of the company’s stock worth $405,000 after acquiring an additional 775 shares during the last quarter. 64.54% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, Director Paul B. Manning sold 200,000 shares of the business’s stock in a transaction that occurred on Thursday, June 4th. The shares were sold at an average price of $63.91, for a total transaction of $12,782,000.00. Following the completion of the transaction, the director owned 716,311 shares in the company, valued at $45,779,436.01. The trade was a 21.83% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Stephen M. Bloch sold 318,893 shares of the stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $50.23, for a total transaction of $16,017,995.39. Following the sale, the director directly owned 1,870,042 shares of the company’s stock, valued at $93,932,209.66. The trade was a 14.57% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 2,200,754 shares of company stock worth $144,924,608. Insiders own 25.60% of the company’s stock.

Liquidia Trading Down 3.1%

LQDA opened at $84.11 on Friday. The firm has a market cap of $7.48 billion, a price-to-earnings ratio of 600.83 and a beta of 0.55. The company has a current ratio of 2.22, a quick ratio of 2.03 and a debt-to-equity ratio of 1.18. Liquidia Corporation has a 12 month low of $16.82 and a 12 month high of $91.10. The stock has a fifty day moving average price of $73.77 and a 200-day moving average price of $51.95.

Liquidia (NASDAQ:LQDA) last released its quarterly earnings results on Monday, May 11th. The company reported $0.52 EPS for the quarter, beating the consensus estimate of $0.41 by $0.11. The business had revenue of $132.87 million during the quarter, compared to analyst estimates of $119.44 million. Liquidia had a net margin of 7.74% and a return on equity of 46.82%. The firm’s revenue was up 4187.1% on a year-over-year basis. As a group, equities research analysts anticipate that Liquidia Corporation will post 3.02 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

LQDA has been the topic of a number of recent analyst reports. HC Wainwright set a $36.00 target price on Liquidia in a research note on Friday, July 24th. Royal Bank Of Canada set a $130.00 target price on shares of Liquidia in a research note on Friday, July 24th. Raymond James Financial restated a “strong-buy” rating and issued a $68.00 price target on shares of Liquidia in a report on Thursday, June 4th. Oppenheimer set a $75.00 price target on shares of Liquidia in a research note on Friday, June 5th. Finally, Wall Street Zen lowered shares of Liquidia from a “strong-buy” rating to a “buy” rating in a report on Saturday, June 27th. Three investment analysts have rated the stock with a Strong Buy rating, five have assigned a Buy rating, one has issued a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, Liquidia currently has a consensus rating of “Moderate Buy” and an average target price of $86.18.

Liquidia Profile

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).